Discovery of anti-infective adipostatins through bioactivity-guided isolation and heterologous expression of a type III polyketide synthase

Lukuan Hou,Ying Li,Qihao Wu,Miyang Li,Ethan A Older,Xiaoyu Tang,Prakash Nagarkatti,Mitzi Nagarkatti,Yuan Liu,Lingjun Li,Daping Fan,Tim S Bugni,Zhuo Shang,Jie Li,Ethan A. Older,Tim S. Bugni

DOI: https://doi.org/10.1016/j.bioorg.2021.104925

IF: 5.307

2021-07-01

Bioorganic Chemistry

Abstract:<p>Antibiotic resistance and emerging viral pandemics have posed an urgent need for new anti-infective drugs. By screening our microbial extract library against the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the notorious ESKAPE pathogens, an active fraction was identified and purified, leading to an initial isolation of adipostatins A (<strong>1</strong>) and B (<strong>2</strong>). In order to diversify the chemical structures of adipostatins toward enhanced biological activities, a type III polyketide synthase was identified from the native producer, <em>Streptomyces davawensis</em> DSM101723, and was subsequently expressed in an <em>E. coli</em> host, resulting in the isolation of nine additional adipostatins <strong>3</strong>–<strong>11</strong>, including two new analogs (<strong>9</strong> and <strong>11</strong>). The structures of <strong>1</strong>–<strong>11</strong> were established by HRMS, NMR, and chemical derivatization, including using a microgram-scale <em>meta</em>-chloroperoxybenzoic acid epoxidation-MS/MS analysis to unambiguously determine the double bond position in the alkyl chain. The present study discovered SARS-CoV-2 main protease inhibitory activity for the class of adipostatins for the first time. Several of the adipostatins isolated also exhibited antimicrobial activity against selected ESKAPE pathogens.</p>

biochemistry & molecular biology,chemistry, organic